Attitudes of patients with gynecological and breast cancer toward integration of complementary medicine in cancer care

International Journal of Gynecological Cancer

Volumn 22, Issue 1, 2012, Pages 146-153

  Ben Arye, Eran ^a,b   Schiff, Elad ^c,d   Steiner, Mariana ^a   Keshet, Yael ^e   Lavie, Ofer ^f  

^a CLALIT HEALTH SERVICES   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c BNAI ZION MEDICAL CENTER   (Israel)

^d UNIVERSITY OF HAIFA   (Israel)

^e BAR ILAN UNIVERSITY   (Israel)

^f CARMEL MEDICAL CENTER   (Israel)

Author keywords

Complementary alternative medicine (cam); Doctor patient communication; Gynecologic oncology; Integrative medicine

Indexed keywords

ADULT; AGE; AGED; ALTERNATIVE MEDICINE; ARTICLE; BREAST CANCER; CLINICAL EFFECTIVENESS; COPING BEHAVIOR; EMOTION; FEMALE; GYNECOLOGIC CANCER; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; PATIENT ATTITUDE; PATIENT COUNSELING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RELIGION; RISK REDUCTION; SAFETY; SPIRITUAL CARE; TREATMENT PLANNING;

AGE FACTORS; AGED; ATTITUDE TO HEALTH; BREAST NEOPLASMS; COMPLEMENTARY THERAPIES; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; ISRAEL; LOGISTIC MODELS; MIDDLE AGED; ODDS RATIO; PHYSICIAN'S ROLE; PHYSICIAN-PATIENT RELATIONS; PROSPECTIVE STUDIES; QUESTIONNAIRES; RELIGION;

EID: 84858260792     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e318226c614     Document Type: Article

References (33)

1. Molassiotis A, Browall M, Milovics L, et al. Complementary and alternative medicine use in patients with gynecological cancers in Europe. Int J Gynecol Cancer. 2006;16(suppl 1): 219-224.
2. Swisher EM, Cohn DE, Goff BA, et al. Use of complementary and alternative medicine among women with gynecologic cancers. Gynecol Oncol. 2002;84:363-367. (Pubitemid 34211858)
3. Von Gruenigen VE, Frasure HE, Jenison EL, et al. Longitudinal assessment of quality of life and lifestyle in newly diagnosed ovarian cancer patients: the roles of surgery and chemotherapy. Gynecol Oncol. 2006;103:120-126. (Pubitemid 44374676)
4. Von Gruenigen VE, White LJ, Kirven MS, et al. A comparison of complementary and alternative medicine use by gynecology and gynecologic oncology patients. Int J Gynecol Cancer. 2001;11:205-209. (Pubitemid 32622667)
5. Navo MA, Phan J, Vaughan C, et al. An assessment of the utilization of complementary and alternative medication in women with gynecologic or breast malignancies. J Clin Oncol. 2004;22:671-677. (Pubitemid 41095070)
6. McKay DJ, Bentley JR, Grimshaw RN. Complementary and alternative medicine in gynaecologic oncology. J Obstet Gynaecol Can. 2005;27:562-568.
7. Supoken A, Chaisrisawatsuk T, Chumworathayi B. Proportion of gynecologic cancer patients using complementary and alternative medicine. Asian Pac J Cancer Prev. 2009;10:779-782.
8. Yildirim Y, Tinar S, Yorgun S, et al. The use of complementary and alternative medicine (CAM) therapies by Turkish women with gynecological cancer. Eur J Gynaecol Oncol. 2006;27:81-85.
9. Chilton JA, Gor BJ, Hajek RA, et al. Cervical cancer among Vietnamese women: efforts to define the problem among Houston's population. Gynaecol Oncol. 2005;99(3 suppl 1): S203-S206. (Pubitemid 41774346)
10. Fasching PA, Thiel F, Nicolaisen-Murmann K, et al. Association of complementary methods with quality of life and life satisfaction in patients with gynecologic and breast malignancies. Support Care Cancer. 2007;15:1277-1284. (Pubitemid 47583442)
11. Markovic M, Manderson L, Wray N, et al. Complementary medicine use by Australian women with gynaecological cancer. Psychooncology. 2006;15:209-220.
12. Rhode JM, Patel DA, Sen A, et al. Perception and use of complementary and alternative medicine among gynecologic oncology care providers. Int J Gynaecol Obstet. 2008;103:111-115.
13. Zheng L, Tong Q, Wu C. Growth-inhibitory effects of curcumin on ovary cancer cells and its mechanisms. J Huazhong Univ Sci Technol Med Sci. 2004;24:55-58. (Pubitemid 41559687)
14. Wahl H, Tan L, Griffith K, et al. Curcumin enhances Apo2L/TRAIL-induced apoptosis in chemoresistant ovarian cancer cells. Gynecol Oncol. 2007;105:104-112. (Pubitemid 46442871)
15. Kuttan G, Vasudevan DM, Kuttan R. Effect of a preparation from Viscum album on tumor development in vitro and in mice. J Ethnopharmacol. 1990;29:35-41. (Pubitemid 20115461)
16. Lian Z, Niwa K, Onogi K, et al. Anti-tumor effects of herbal medicines on endometrial carcinomas via estrogen receptor-alpha-related mechanism. Oncol Rep. 2006;15: 1133-1136.
17. Tagami K, Niwa K, Lian Z, et al. Preventive effect of Juzen-taiho-to on endometrial carcinogenesis in mice is based on Shimotsu-to constituent. Biol Pharm Bull. 2004;27:156-161. (Pubitemid 41694689)
18. Pongnikorn S, Fongmoon D, Kasinrerk W, et al. Effect of bitter melon (Momordica charantia Linn) on level and function of natural killer cells in cervical cancer patients with radiotherapy. J Med Assoc Thai. 2003;86:61-68. (Pubitemid 36534714)
19. Minig L, Trimble EL, Birrer MJ, et al. NIH and NCI support for development of novel therapeutics in gynecologic cancer: a user's guide. Gynecol Oncol. 2010;116:177-180.
20. León-Pizarro C, Gich I, Barthe E, et al. A randomized trial of the effect of training in relaxation and guided imagery techniques in improving psychological and quality-of-life indices for gynecologic and breast brachytherapy patients. Psycho-oncology. 2007;16:971-979. (Pubitemid 350081657)
21. Danhauer SC, Tooze JA, Farmer DF, et al. Restorative yoga for women with ovarian or breast cancer: findings from a pilot study. J Soc Integr Oncol. 2008;6:47-58. (Pubitemid 351930972)
22. You Q, Yu H, Wu D, et al. Vitamin B6 points PC6 injection during acupuncture can relieve nausea and vomiting in patients with ovarian cancer. Int J Gynecol Cancer. 2009;19:567-571.
23. Lu W, Matulonis UA, Doherty-Gilman A, et al. Acupuncture for chemotherapy-induced neutropenia in patients with gynecologic malignancies: a pilot randomized, sham-controlled clinical trial. J Altern Complement Med. 2009;15:745-753.
24. Kienle GS, Glockmann A, Schink M, et al. Viscum album L. extracts in breast and gynaecological cancers: a systematic review of clinical and preclinical research. J Exp Clin Cancer Res. 2009;28:79.
25. Piao BK, Wang YX, Xie GR, et al. Impact of complementary mistletoe extract treatment on quality of life in breast, ovarian and non-small cell lung cancer patients. A prospective randomized controlled clinical trial. Anticancer Res. 2004;24:303-309. (Pubitemid 38279723)
26. Ahn WS, Kim DJ, Chae GT, et al. Natural killer cell activity and quality of life were improved by consumption of a mushroom extract, Agaricus blazei Murill Kyowa, in gynecological cancer patients undergoing chemotherapy. Int J Gynecol Cancer. 2004;14:589-594.
27. Sieja K, Talerczyk M. Selenium as an element in the treatment of ovarian cancer in women receiving chemotherapy. Gynecol Oncol. 2004;93:320-327. (Pubitemid 38507596)
28. Muecke R, Schomburg L, Glatzel M, et al, on behalf of the German Working Group Trace Elements and Electrolytes in Oncology-AKTE. Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology. Int J Radiat Oncol Biol Phys. 2010;78:828-835.
29. Delia P, Sansotta G, Donato V, et al. Use of probiotics for prevention of radiation-induced diarrhea. World J Gastroenterol. 2007;13:912-915. (Pubitemid 46470303)
30. Grossarth-Maticek R, Ziegler R. Prospective controlled cohort studies on long-term therapy of ovarian cancer patients with mistletoe (Viscum album L.) extracts Iscador. Arzneimittelforschung. 2007;57:665-678. (Pubitemid 350075413)
31. Grossarth-Maticek R, Ziegler R. Randomized and non-randomized prospective controlled cohort studies in matched pair design for the long-term therapy of corpus uteri cancer patients with a mistletoe preparation (Iscador). Eur J Med Res. 2008;13:107-120. (Pubitemid 351559881)
32. Grossarth-Maticek R, Ziegler R. Prospective controlled cohort studies on long-term therapy of cervical cancer patients with a mistletoe preparation (Iscador). Forsch Komplementmed. 2007;14:140-147. (Pubitemid 47013381)
33. Clait Health Organization activity profile. Available at: http://www.microsoft.com/israel/casestudies/clalit-sql.mspx. Accessed December 18, 2010.